Hints and tips:
Related Special Reports
...Vertex’s blockbuster cystic fibrosis drug Trikafta and BeiGene’s blood cancer drug Brukinsa are both produced in part at WuXi facilities, according to GlobalData, an analytics firm....
...With Game of Thrones creators DB Weiss and David Benioff and True Blood writer Alexander Woo as showrunners, Netflix’s 3 Body Problem — on which Liu is listed as a consulting producer — registered 11mn views...
...The New York-based pharma group has acquired four companies — Arena, ReViral, Biohaven and Global Blood Therapeutics — that it expects will contribute about $10bn in revenues in 2030....
...“More of the largest institutional investors in the world are more interested in what we have to say today than they were three years ago,” says David Blood, who founded sustainable investing specialist...
...The therapy — Casgevy, developed by US biotech company Vertex Pharmaceuticals and Crispr Therapeutics for the blood disorders sickle cell disease and beta thalassaemia — has since been approved by the European...
...Crispr has been applied to blood disorders first because the cells are easier to extract to edit their genes....
...Apple is the global market leader in smartwatches, with an estimated 22 per cent share of unit shipments in the third quarter, according to Counterpoint Research....
...streak lately, with back-to-back losses including Amgen’s $28bn takeover of fellow drugmaker Horizon Therapeutics and Microsoft’s $75bn purchase of game developer Activision Blizzard....
...Molnupiravir’s original UK approval in November 2021 was a global first....
...The likely ban follows a challenge from medical device maker Masimo, which claimed Apple breached two of its patents on pulse oximetry, a technology for monitoring the oxygen level in blood....
...The global environmental protection organisation lists the American horseshoe crab as “vulnerable”....
...Mergers and acquisitions are Wall Street’s blood sport. Winning a deal is of paramount importance. So anyone who gets in the way of achieving that goal draws ire....
...Private credit co-heads James Reynolds and Kevin Sterling have also been named global head of direct lending and global head of investment-grade private credit and asset finance, respectively....
...In a separate “cell culture” lab, one scientist was examining blood samples from people vaccinated against Covid-19....
...In 2022 the country spent more than $600bn on medicines, almost half the total global outlay, according to Statista....
...The FT’s global head of audio is Cheryl Brumley. The show’s theme song is by Metaphor Music. Read a transcript of this episode on FT.com...
...Pfizer is close to acquiring Global Blood Therapeutics for about $5bn as the drugmaker taps the huge cash pile generated by the success of its Covid-19 vaccine to replenish its pipeline, according to people...
...As the EU approved Microsoft’s $75bn bid to buy Activision Blizzard, the US Federal Trade Commission sued to block Amgen’s $28.3bn deal to acquire Horizon Therapeutics and warned of “rampant consolidation...
...The US drugmaker has spent almost $30bn on acquisitions over the past two years, snapping up Arena Pharmaceuticals, Biohaven Pharmaceuticals, Global Blood Therapeutics, ReViral and Trillium Therapeutics....
...Tim Walbert, Horizon’s chief executive, suffers from an autoimmune condition himself, and previously led the global development of Abbvie’s blockbuster Humira....
...Citigroup has promoted Flavio Figueiredo to global head of foreign exchange, based in New York. Houlihan Lokey has agreed to acquire 7 Mile Advisors....
...The product, developed by Vertex Pharmaceuticals and Crispr Therapeutics of the US, corrects the gene defect that causes sickle cell disease, a blood disorder....
...He added that oncology continued to be “the largest growth driver in global medicine” so the deal contributed to Pfizer’s near and long-term financial goals....
...It’s litigating an order for Illumina to divest cancer screening company Grail in a vertical merger case and has also sued to block Amgen’s $28bn takeover of Horizon Therapeutics....
International Edition